Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/ced.14858 http://scihub22266oqcxt.onion/10.1111/ced.14858 34291477!8444843!34291477     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34291477&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Clin+Exp+Dermatol 2022 ; 47 (1): 161-163 Nephropedia Template TP {{tp|p=34291477|t=2022. Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination |pdf=|usr=}}{{34291477}} gab.com Text Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination JO: Clin Exp Dermatol http://www.kidney.de/pget.php?&tw=1&pmid=34291477 #FOAvip Evidence is accumulating that COVID-19 vaccines might induce or exacerbate autoimmune rheumatic diseases. The currently available COVID-19 vaccines include mRNA and recombinant adenoviral vector vaccines, both encoding SARS-CoV-2 spike protein production as the primary target for neutralizing antibodies. We report a case of subacute cutaneous lupus erythematosus (SCLE) following mRNA vaccination with the Pfizer mRNA vaccine BNT162b2, and summarize the current literature on CLE occurring after COVID-19 vaccination. Twit Text FOAVip Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination ????Clin Exp Dermatol http://www.kidney.de/pget.php?&tw=1&pmid=34291477 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34291477 #FOAvip English Wikipedia <ref>{{Cite pmid|34291477}}</ref> Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination #MMPMID34291477 Kreuter A; Licciardi-Fernandez MJ; Burmann SN; Burkert B; Oellig F; Michalowitz AL Clin Exp Dermatol 2022[Jan]; 47 (1): 161-163 PMID34291477show ga Evidence is accumulating that COVID-19 vaccines might induce or exacerbate autoimmune rheumatic diseases. The currently available COVID-19 vaccines include mRNA and recombinant adenoviral vector vaccines, both encoding SARS-CoV-2 spike protein production as the primary target for neutralizing antibodies. We report a case of subacute cutaneous lupus erythematosus (SCLE) following mRNA vaccination with the Pfizer mRNA vaccine BNT162b2, and summarize the current literature on CLE occurring after COVID-19 vaccination. |Ad26COVS1/adverse effects[MESH] |Aged[MESH] |BNT162 Vaccine/*adverse effects[MESH] |COVID-19/*prevention & control[MESH] |ChAdOx1 nCoV-19/adverse effects[MESH] |Drug Eruptions/*etiology[MESH] |Humans[MESH] |Lupus Erythematosus, Cutaneous/*chemically induced[MESH] |Male[MESH] |SARS-CoV-2[MESH]Induction and exacerbation of subacute cutaneous lupus erythematosus f(epmc).pdf DeepDyve Pubget Overpricing